Editas Medicine, Inc.
Records under this name other than the patents Editas Medicine, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 47 patents it holds.
Showing 1 to 7 of 7 · Back to Editas Medicine, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,834,791 | CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING gRNAS Formerly held In force · High confidence | In force | High confidence | |
| US 10,190,137 | CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING gRNAS Formerly held In force · High confidence | In force | High confidence | |
| US 10,640,788 | CRISPR-Related Methods and Compositions with Governing Grnas Formerly held In force · High confidence | In force | High confidence | |
| US 11,390,887 | CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING gRNAS Formerly held In force · High confidence | In force | High confidence | |
| US 11,390,861 | CRISPR/Cas-Related Methods and Compositions for Treating Herpes Simplex Virus Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,952,408 | Hpv-Specific Binding Molecules Formerly held In force · High confidence | In force | High confidence | |
| US 12,331,328 | CRISPR/Cas9-Mediated Exon-Skipping Approach for USH2A-Associated Usher Syndrome Formerly held In force · High confidence | In force | High confidence |